Last update 01 Nov 2024

Crossignal Therapeutics, Inc.

Private Company|
2019|
United States

Overview

Basic Info

Introduction
Crossignal Therapeutics is developing new generation of small molecule anti-cancer immunotherapies. They focus on the discovery of immune cell-expressed, tumor metabolic factors (TME)-targeted GPCRs (TMERs) and design drug candidates by testing their ability to inhibit critical pathways in TME-mediated cancer immune escape.

Tags

Neoplasms
Digestive System Disorders
Endocrinology and Metabolic Disease
Small molecule drug
Chemical drugs

Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Small molecule drug6
Chemical drugs1

Corporation Tree

Boost your research with our corporation tree data.
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 27 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
2
3
Preclinical
Phase 2 Clinical
2
1
Other
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
TMER1-i
Colonic Cancer
More
Phase 2 Clinical
CT-3001
( GPR35 )
Colorectal Cancer
More
Phase 2 Clinical
Adenosine Blocker(Crossignal Therapeutics)
Solid tumor
More
Preclinical
CT-3021
( A1R x A2aR x A3R )
Neoplasms
More
Preclinical
PD1/PD-L1 Blocker(Crossignal Therapeutics)
Solid tumor
More
Preclinical
Login to view more data

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free